Protalix Biotherapeutics Inc (PLX)
Revenue
$80.62M
TTM · Period ending: · USD
PLX Revenue
Latest reported$80.62Mperiod ending
Latest reported$80.62Mperiod ending
PLX TTM Revenue ($0.00 → $80.62M)
TTM revenue
High-resolution chart · PNG
PLX revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 80,619,000 | |
| 76,381,000 | |
| 52,744,000 | |
| 61,840,000 | |
| 61,948,000 | |
| 59,764,000 | |
| 53,399,000 | |
| 45,667,000 | |
| 38,053,000 | |
| 59,654,000 | |
| 65,494,000 | |
| 63,625,000 | |
| 67,463,000 | |
| 41,141,000 | |
| 47,638,000 | |
| 47,570,000 | |
| 45,441,000 | |
| 43,115,000 | |
| 38,350,000 | |
| 49,296,000 | |
| 48,032,000 | |
| 52,572,000 | |
| 62,898,000 | |
| 61,162,000 | |
| 64,620,000 | |
| 65,900,000 | |
| 54,693,000 | |
| 63,952,000 | |
| 62,039,000 | |
| 54,630,000 | |
| 48,744,000 | |
| 24,195,000 | |
| 19,386,000 | |
| 20,906,000 | |
| 19,242,000 | |
| 18,854,000 | |
| 15,998,000 | |
| 11,409,000 | |
| 9,199,000 | |
| -4,077,000 | |
| -2,901,000 | |
| -3,334,000 | |
| -2,321,000 | |
| 10,258,000 | |
| 8,119,000 | |
| 9,469,000 | |
| 15,160,000 | |
| 14,898,000 | |
| 14,550,000 | |
| 14,928,000 | |
| 11,513,000 | |
| 10,439,000 | |
| 12,470,000 | |
| 34,664,000 | |
| 34,424,000 | |
| 36,738,000 | |
| 32,480,000 | |
| 7,986,000 | |
| 10,258,000 | |
| 9,072,000 | |
| 11,124,000 | |
| 11,501,000 | |
| 6,642,000 | |
| 5,854,000 | |
| 2,670,000 | |
| 1,529,000 | |
| 388,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 150,000 | |
| 150,000 | |
| 150,000 | |
| 150,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1 | |
| 1 | |
| 1 |